179 Views | 199 Downloads
Corresponding Author: Colin Derdeyn, MD, 510 South Kingshighway Blvd., St Louis, MO 63110, Tel: 314 362-3225; Fax 314 362-2530, derdeync@wustl.edu
See publication for full list of disclosures.
The SAMMPRIS trial was funded by a research grant (U01 NS058728) from the US Public Health Service National Institute of Neurological Disorders and Stroke (NINDS).
In addition, the following Clinical and Translational Science Awards, funded by the National Institutes of Health, provided local support for the evaluation of patients in the trial: Medical University of South Carolina (UL1RR029882), University of Florida (UL1RR029889), University of Cincinnati (UL1RR029890), and University of California, San Francisco (UL1RR024131).
Stryker Neurovascular (formerly Boston Scientific Neurovascular) provided study devices and supplemental funding for third party device distribution, site monitoring and study auditing.
This research is also supported by the Investigator-Sponsored Study Program of AstraZeneca that donates rosuvastatin (Crestor) to study patients.
© 2013 by the Congress of Neurological Surgeons.